Finally, we showed that treatment of anovulatory GK rats with rMab22A2 also reduced the androgen levels and unlocked the oestrous cycle of anovulatory GK rats, counteracting two putative effects of AMH in the PCOS. This evidence concerns the gene AMH and polycystic ovary syndrome.